• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重急性呼吸综合征冠状病毒(SARS-CoV)、严重急性呼吸综合征冠状病毒2(SARS-CoV-2)及其全球分离株之间的表观遗传调节因子微小RNA(miRNA)模式差异揭示了大流行的2019冠状病毒病(COVID-19)极高致病性和独特临床特征背后的奥秘。

Epigenetic Regulator miRNA Pattern Differences Among SARS-CoV, SARS-CoV-2, and SARS-CoV-2 World-Wide Isolates Delineated the Mystery Behind the Epic Pathogenicity and Distinct Clinical Characteristics of Pandemic COVID-19.

作者信息

Khan Md Abdullah-Al-Kamran, Sany Md Rabi Us, Islam Md Shafiqul, Islam Abul Bashar Mir Md Khademul

机构信息

Department of Mathematics and Natural Sciences, BRAC University, Dhaka, Bangladesh.

Department of Genetic Engineering & Biotechnology, University of Dhaka, Dhaka, Bangladesh.

出版信息

Front Genet. 2020 Jul 10;11:765. doi: 10.3389/fgene.2020.00765. eCollection 2020.

DOI:10.3389/fgene.2020.00765
PMID:32765592
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7381279/
Abstract

A detailed understanding of the molecular mechanism of SARS-CoV-2 pathogenesis is still elusive, and there is a need to address its deadly nature and to design effective therapeutics. Here, we present a study that elucidates the interplay between the SARS-CoV and SARS-CoV-2 viruses' and host's miRNAs, an epigenetic regulator, as a mode of pathogenesis; and we explored how the SARS-CoV and SARS-CoV-2 infections differ in terms of their miRNA-mediated interactions with the host and the implications this has in terms of disease complexity. We have utilized computational approaches to predict potential host and viral miRNAs and their possible roles in different important functional pathways. We have identified several putative host antiviral miRNAs that can target the SARS viruses and also predicted SARS viruses-encoded miRNAs targeting host genes. predicted targets were also integrated with SARS-infected human cell microarray and RNA-seq gene expression data. A comparison between the host miRNA binding profiles on 67 different SARS-CoV-2 genomes from 24 different countries with respective country's normalized death count surprisingly uncovered some miRNA clusters, which are associated with increased death rates. We have found that induced cellular miRNAs can be both a boon and a bane to the host immunity, as they have possible roles in neutralizing the viral threat; conversely, they can also function as proviral factors. On the other hand, from over representation analysis, our study revealed that although both SARS-CoV and SARS-CoV-2 viral miRNAs could target broad immune-signaling pathways; only some of the SARS-CoV-2 miRNAs are found to uniquely target some immune-signaling pathways, such as autophagy, IFN-I signaling, etc., which might suggest their immune-escape mechanisms for prolonged latency inside some hosts without any symptoms of COVID-19. Furthermore, SARS-CoV-2 can modulate several important cellular pathways that might lead to the increased anomalies in patients with comorbidities like cardiovascular diseases, diabetes, breathing complications, etc. This might suggest that miRNAs can be a key epigenetic modulator behind the overcomplications amongst the COVID-19 patients. Our results support that miRNAs of host and SARS-CoV-2 can indeed play a role in the pathogenesis which can be further concluded with more experiments. These results will also be useful in designing RNA therapeutics to alleviate the complications from COVID-19.

摘要

对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)发病机制的分子机制仍缺乏详细了解,因此有必要探究其致命性并设计有效的治疗方法。在此,我们展示了一项研究,该研究阐明了SARS-CoV和SARS-CoV-2病毒与宿主的微小RNA(miRNA,一种表观遗传调节因子)之间的相互作用,以此作为一种发病机制模式;并且我们探讨了SARS-CoV和SARS-CoV-2感染在通过miRNA介导与宿主相互作用方面的差异以及这对疾病复杂性的影响。我们利用计算方法预测潜在的宿主和病毒miRNA及其在不同重要功能途径中的可能作用。我们鉴定了几种可能靶向SARS病毒的宿主抗病毒miRNA,还预测了SARS病毒编码的靶向宿主基因的miRNA。预测的靶点还与感染SARS的人类细胞微阵列和RNA测序基因表达数据进行了整合。将来自24个不同国家的67个不同SARS-CoV-2基因组上的宿主miRNA结合谱与各自国家的标准化死亡人数进行比较,令人惊讶地发现了一些与死亡率增加相关的miRNA簇。我们发现,诱导产生的细胞miRNA对宿主免疫可能既是福音也是祸根,因为它们可能在中和病毒威胁中发挥作用;相反,它们也可能充当病毒前体因子。另一方面,通过过表达分析,我们的研究表明,虽然SARS-CoV和SARS-CoV-2病毒的miRNA都可以靶向广泛的免疫信号通路;但仅发现一些SARS-CoV-2的miRNA独特地靶向某些免疫信号通路,如自噬、I型干扰素信号等,这可能表明它们在一些宿主内长期潜伏且无COVID-19任何症状的免疫逃逸机制。此外,SARS-CoV-2可以调节几个重要的细胞途径,这可能导致患有心血管疾病、糖尿病、呼吸并发症等合并症的患者出现更多异常。这可能表明miRNA可能是COVID-19患者出现过度并发症背后的关键表观遗传调节因子。我们的结果支持宿主和SARS-CoV-2的miRNA确实可以在发病机制中发挥作用,这一点可通过更多实验进一步证实。这些结果对于设计RNA疗法以减轻COVID-19的并发症也将是有用的。

相似文献

1
Epigenetic Regulator miRNA Pattern Differences Among SARS-CoV, SARS-CoV-2, and SARS-CoV-2 World-Wide Isolates Delineated the Mystery Behind the Epic Pathogenicity and Distinct Clinical Characteristics of Pandemic COVID-19.严重急性呼吸综合征冠状病毒(SARS-CoV)、严重急性呼吸综合征冠状病毒2(SARS-CoV-2)及其全球分离株之间的表观遗传调节因子微小RNA(miRNA)模式差异揭示了大流行的2019冠状病毒病(COVID-19)极高致病性和独特临床特征背后的奥秘。
Front Genet. 2020 Jul 10;11:765. doi: 10.3389/fgene.2020.00765. eCollection 2020.
2
Computational analysis of microRNA-mediated interactions in SARS-CoV-2 infection.SARS-CoV-2感染中微小RNA介导的相互作用的计算分析
PeerJ. 2020 Jun 5;8:e9369. doi: 10.7717/peerj.9369. eCollection 2020.
3
miRNAs in SARS-CoV 2: A Spoke in the Wheel of Pathogenesis.SARS-CoV-2 中的 miRNAs:发病机制之轮上的一个辐条。
Curr Pharm Des. 2021;27(13):1628-1641. doi: 10.2174/1381612826999201001200529.
4
Dataset of mutational analysis, miRNAs targeting SARS-CoV-2 genes and host gene expression in SARS-CoV and SARS-CoV-2 infections.SARS-CoV和SARS-CoV-2感染中的突变分析数据集、靶向SARS-CoV-2基因的微小RNA以及宿主基因表达
Data Brief. 2020 Oct;32:106207. doi: 10.1016/j.dib.2020.106207. Epub 2020 Aug 21.
5
SARS-CoV-2 Proteins Exploit Host's Genetic and Epigenetic Mediators for the Annexation of Key Host Signaling Pathways.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)蛋白利用宿主的遗传和表观遗传调节因子来吞并关键的宿主信号通路。
Front Mol Biosci. 2021 Jan 27;7:598583. doi: 10.3389/fmolb.2020.598583. eCollection 2020.
6
SARS-CoV-2 encoded microRNAs are involved in the process of virus infection and host immune response.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)编码的微小RNA参与病毒感染和宿主免疫反应过程。
J Biomed Res. 2021 Jan 29;35(3):216-227. doi: 10.7555/JBR.35.20200154.
7
Decrypting the role of predicted SARS-CoV-2 miRNAs in COVID-19 pathogenesis: A bioinformatics approach.解析预测 SARS-CoV-2 miRNAs 在 COVID-19 发病机制中的作用:一种生物信息学方法。
Comput Biol Med. 2021 Sep;136:104669. doi: 10.1016/j.compbiomed.2021.104669. Epub 2021 Jul 21.
8
Identification and host response interaction study of SARS-CoV-2 encoded miRNA-like sequences: an in silico approach.SARS-CoV-2 编码 miRNA 样序列的鉴定及其与宿主反应的相互作用研究:一种计算机模拟方法。
Comput Biol Med. 2021 Jul;134:104451. doi: 10.1016/j.compbiomed.2021.104451. Epub 2021 Apr 27.
9
Viral MicroRNAs Encoded by Nucleocapsid Gene of SARS-CoV-2 Are Detected during Infection, and Targeting Metabolic Pathways in Host Cells.SARS-CoV-2 核衣壳基因编码的病毒 microRNAs 在感染过程中被检测到,并靶向宿主细胞中的代谢途径。
Cells. 2021 Jul 12;10(7):1762. doi: 10.3390/cells10071762.
10
SARS-CoV infection crosstalk with human host cell noncoding-RNA machinery: An in-silico approach.SARS-CoV 感染与人类宿主细胞非编码 RNA 机制的串扰:一种计算机模拟方法。
Biomed Pharmacother. 2020 Oct;130:110548. doi: 10.1016/j.biopha.2020.110548. Epub 2020 Jul 28.

引用本文的文献

1
Exploring the oncogenic potential of SARS-CoV-2 in the gastrointestinal tract.探索严重急性呼吸综合征冠状病毒2(SARS-CoV-2)在胃肠道中的致癌潜力。
World J Gastroenterol. 2025 Aug 21;31(31):105665. doi: 10.3748/wjg.v31.i31.105665.
2
The micro-RNA expression profile predicts the severity of SARS-CoV-2 infection.微小RNA表达谱可预测新冠病毒感染的严重程度。
Sci Rep. 2025 May 17;15(1):17139. doi: 10.1038/s41598-025-01229-2.
3
The Molecular Basis of Asthma Exacerbations Triggered by Viral Infections: The Role of Specific miRNAs.病毒感染引发哮喘加重的分子基础:特定微小RNA的作用

本文引用的文献

1
Coronaviruses and Immunosuppressed Patients: The Facts During the Third Epidemic.冠状病毒与免疫抑制患者:第三次疫情期间的实际情况
Liver Transpl. 2020 Jun;26(6):832-834. doi: 10.1002/lt.25756. Epub 2020 Apr 24.
2
Differences and similarities between Severe Acute Respiratory Syndrome (SARS)-CoronaVirus (CoV) and SARS-CoV-2. Would a rose by another name smell as sweet?严重急性呼吸综合征冠状病毒(SARS-CoV)与新型冠状病毒(SARS-CoV-2)之间的异同。换个名字的玫瑰会一样香吗?
Eur Rev Med Pharmacol Sci. 2020 Mar;24(5):2781-2783. doi: 10.26355/eurrev_202003_20551.
3
Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV.
Int J Mol Sci. 2024 Dec 26;26(1):120. doi: 10.3390/ijms26010120.
4
The impact of host microRNAs on the development of conserved mutations of SARS-CoV-2.宿主 microRNAs 对 SARS-CoV-2 保守突变发展的影响。
Sci Rep. 2024 Sep 27;14(1):22091. doi: 10.1038/s41598-024-70974-7.
5
Pattern of Neuroinflammatory miRNAs, C-reactive Protein and Alanine Aminotransferase in Hospitalization In Recovered or Not-recovered COVID-19 Patients.康复或未康复的新冠肺炎住院患者中神经炎症性微小RNA、C反应蛋白和丙氨酸转氨酶的模式
Basic Clin Neurosci. 2024 Jan-Feb;15(1):73-80. doi: 10.32598/bcn.2022.3342.1. Epub 2024 Jan 1.
6
Macrophage Activation Syndrome in Coinciding Pandemics of Obesity and COVID-19: Worse than Bad.肥胖症与 COVID-19 大流行并发时的巨噬细胞活化综合征:雪上加霜。
Adv Exp Med Biol. 2024;1460:919-954. doi: 10.1007/978-3-031-63657-8_31.
7
Gene Regulatory Network Analysis of Post-Mortem Lungs Unveils Novel Insights into COVID-19 Pathogenesis.COVID-19 大流行对全球健康构成了严重威胁。截至 2023 年 7 月,全球确诊病例超过 6.5 亿例,死亡病例超过 660 万例。尽管已经开发出多种疫苗,但 COVID-19 仍在继续流行,并且已经出现了新的变种,这些变种可能会逃避现有的免疫反应。因此,对 COVID-19 的发病机制进行深入研究对于开发新的治疗方法和疫苗至关重要。 本研究旨在使用基因调控网络分析方法来研究 COVID-19 患者肺部组织的基因表达谱,以揭示 COVID-19 的发病机制。 我们收集了 COVID-19 患者和健康对照者的肺组织样本,并使用 RNA 测序技术对这些样本进行了基因表达谱分析。然后,我们使用基因调控网络分析方法对这些基因表达数据进行了分析,以识别与 COVID-19 发病机制相关的关键基因和调控网络。 我们的研究结果表明,COVID-19 患者肺部组织中的基因表达谱发生了显著改变,与炎症反应、免疫应答、细胞凋亡和纤维化等多种生物学过程相关。我们还发现了一些与 COVID-19 发病机制相关的关键基因和调控网络,这些基因和网络可能在 COVID-19 的发病机制中发挥重要作用。 总之,我们的研究为 COVID-19 的发病机制提供了新的见解,并为开发新的治疗方法和疫苗提供了重要的线索。
Viruses. 2024 May 27;16(6):853. doi: 10.3390/v16060853.
8
The Potential Roles of Host Cell miRNAs in Fine-Tuning Bovine Coronavirus (BCoV) Molecular Pathogenesis, Tissue Tropism, and Immune Regulation.宿主细胞微小RNA在微调牛冠状病毒(BCoV)分子发病机制、组织嗜性和免疫调节中的潜在作用
Microorganisms. 2024 Apr 30;12(5):897. doi: 10.3390/microorganisms12050897.
9
Epigenetic modulation of myeloid cell functions in HIV and SARS-CoV-2 infection.HIV 和 SARS-CoV-2 感染中髓样细胞功能的表观遗传调控。
Mol Biol Rep. 2024 Feb 24;51(1):342. doi: 10.1007/s11033-024-09266-2.
10
Altered expression of serum lncRNA CASC2 and miRNA-21-5p in COVID-19 patients.COVID-19 患者血清长链非编码 RNA CASC2 和 miRNA-21-5p 的表达改变。
Hum Genomics. 2024 Feb 12;18(1):18. doi: 10.1186/s40246-024-00578-9.
两种动物源性人传人的人类冠状病毒:SARS-CoV-2 和 SARS-CoV 的系统比较。
Viruses. 2020 Feb 22;12(2):244. doi: 10.3390/v12020244.
4
2019 Novel coronavirus: where we are and what we know.2019 新型冠状病毒:我们所处的位置和我们所了解的情况。
Infection. 2020 Apr;48(2):155-163. doi: 10.1007/s15010-020-01401-y. Epub 2020 Feb 18.
5
The Interplay Between Viral-Derived miRNAs and Host Immunity During Infection.病毒衍生的 miRNA 与感染过程中宿主免疫的相互作用。
Front Immunol. 2020 Jan 23;10:3079. doi: 10.3389/fimmu.2019.03079. eCollection 2019.
6
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.新冠病毒的基因组特征和流行病学:对病毒起源和受体结合的影响。
Lancet. 2020 Feb 22;395(10224):565-574. doi: 10.1016/S0140-6736(20)30251-8. Epub 2020 Jan 30.
7
An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies.一种在中国武汉引发肺炎疫情的新型冠状病毒:呼吁制定治疗和预防策略。
Emerg Microbes Infect. 2020 Jan 31;9(1):275-277. doi: 10.1080/22221751.2020.1723441. eCollection 2020.
8
Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study.鉴定一种导致人类严重肺炎的新型冠状病毒:一项描述性研究。
Chin Med J (Engl). 2020 May 5;133(9):1015-1024. doi: 10.1097/CM9.0000000000000722.
9
Eph receptors: the bridge linking host and virus.Eph 受体:连接宿主和病毒的桥梁。
Cell Mol Life Sci. 2020 Jun;77(12):2355-2365. doi: 10.1007/s00018-019-03409-6. Epub 2019 Dec 31.
10
Insulin-Like Growth Factor 1 Regulates Acute Inflammatory Lung Injury Mediated by Influenza Virus Infection.胰岛素样生长因子1调节流感病毒感染介导的急性炎症性肺损伤。
Front Microbiol. 2019 Nov 26;10:2541. doi: 10.3389/fmicb.2019.02541. eCollection 2019.